Delivery Order SPE2DB24D9238-SPE2DB25FDRBV
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for $6,189.60 to supply Xolair 150 mg/ml syringes. The delivery order, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, carries firm fixed pricing and does not include a set-aside designation. This award is issued under DMS Pharmaceutical Group's larger single-award Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,860.48 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml syringes. This firm fixed-price delivery order, issued on August 27, 2025, with an ultimate completion date of September 18, 2025, represents a standalone procurement without set-aside designation. The delivery is to be performed in Park Ridge, Illinois, where...
- The Defense Logistics Agency awarded a $1,547.40 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of XOLAIR 150 mg/ml syringes. The contract is firm fixed-price with an ultimate completion date of September 18, 2025, and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately $500 million...
- The Defense Logistics Agency has awarded a delivery order valued at $3,868.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the provision of Xolair 150 mg/ml syringes. The contract is firm fixed-price with an ultimate completion date of September 17, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,642.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 75 mg/0.5 ml syringes. The delivery order, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, carries no set-aside designation. DMS Pharmaceutical Group is executing this order under its larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,284.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/1.2 ml powder vials. The contract is firm fixed-price with an ultimate completion date of September 9, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,284.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a targeted procurement of a biologic medication used primarily in the treatment of moderate-to-severe allergic asthma and...
- The Defense Logistics Agency (DLA) awarded a delivery order contract worth $30,948.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of Xolair 150 mg/ml syringes, a specialty pharmaceutical product, with a period of performance through June 11, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml syringes. The contract, valued at $27,907.20 with a firm fixed-price structure, is scheduled for completion by September 5, 2025, and was awarded on August 14, 2025. This delivery order carries no set-aside designation and leverages DMS Pharmaceutical Group's existing Indefinite...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $19,839.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL syringes. The delivery order, issued on September 17, 2025, with an ultimate completion date of October 8, 2025, was awarded without a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB25FDRBVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $44,651.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml syringes. This firm fixed-price delivery order, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, represents a standard procurement action with no set-aside designation. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which authorizes the agency to issue delivery orders for a comprehensive range of pharmaceutical items supporting military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in DLA procurement markets. The company specializes in distributing branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to Department of Defense healthcare facilities. This particular delivery order for Xolair, a biologic therapy commonly used for severe asthma and urticaria treatment, exemplifies the vendor's capability to supply specialized pharmaceutical products directly to military medical supply needs across the United States.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.7k | 9/18/25 |